August 1, 2026Journal of the American College of Cardiology
Risk of Myocarditis and Pericarditis With Bivalent RSV Prefusion F Protein-Based Vaccine
Marat YafasovMats C Højbjerg LassenManan PareekSine H. ChristensenNiklas Dyrby JohansenAbby E. RudolphCarmen Rodríguez-Tenreiro-SánchezKristoffer Grundtvig SkaarupDaniel ModinBrian L. ClaggettCarsten S. LarsenLykke LarsenLothar WieseMichael Dalager-PedersenMatias G. LindholmAnne Marie Reimer JensenMaria DonsK Feldballe BernholmFilip S. DavidovskiLisa Steen DuusCamilla I. OttosenAnne Bjerg NielsenJulie H. BorchseniusCaroline EspersenGüldas KöseFrederik H. FussingIngrid T. LenzJacob ChristensenJakob Ø. SimonsenMajid AfzalKatja V. BartholdyAdam C.F. LanghoffMaj Beldring HenningsenDanny Witten DavodianLars KøberScott D. SolomonJens Ulrik Stæhr JensenCyril Jean-Marie MartelIago Giné-VázquezCarmen Duran-ParrondoMarta Piñeiro-SoteloMartín Cribeiro-GonzálezMónica Conde-PájaroSusana Mirás-CarballalJuan-Manuel González-PérezBradford D. GessnerNegar AliabadiClaudia SchwarzMette SkovdalLawrence H. MoultonPingping ZhangV. López-GómezSabrina WelshLaura Anatale‐TardiffAlejandro CaneKyla HayfordFederico Martinón-TorresElizabeth BegierTor Biering-Sørensen
No abstract yet
We only have this paper's title and publication details.
Read it at the sourceAsk about this paper
Answers are grounded in this paper and cite their sources.
Key expert perspectives
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“myocarditis or pericarditis to be exceedingly rare for RSVpreF”
HYHelen Y. ChuInfectious disease physician, University of Washington
“Together, these data provide real-world evidence to support RSV vaccination, while highlighting the need to better define re-vaccination schedules.”
Coverage & sources
Journal, society, and media accounts. Useful signal, not independent expert judgment.
Discussion
No takes yet. Share an insight, caveat, or question.
Cite This Study
Yafasov et al. (2026) studied this question.